The Albumin Market size was valued at USD 5.95 Billion in 2024 and the total Albumin revenue is expected to grow at a CAGR of 5.21% from 2025 to 2032, reaching nearly USD 8.93 Billion.Albumin Market Overview:
The Albumin is a water-soluble globular protein formed in the liver accounting for 50% of blood plasma proteins. Albumin plays an important role in regulating blood volume and act as transporters for molecules like few hormones, bile salts and ions. It is mostly used as blood volumizer in infrequent diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries. It supports in the stabilization of drugs by reducing aggregation, oxidation, and surface absorption. Various type of serum albumin are widely used for clinical applications. Human serum albumin and bovine serum albumin are found in human plasma and bovine plasma, respectively. On the other hand, recombinant albumin is manufactured by recombinant techniques in yeast and bacteria strains.To know about the Research Methodology :- Request Free Sample Report
Albumin Market Dynamics:
One of the primary factors driving the market's growth is the rising popularity of chronic medical conditions around the world. Albumin is commonly used to treat hypovolemia, ARDS, nephrosis, renal dialysis, liver failure, cardiac diseases, and hypoalbuminemia. Furthermore, the growing geriatric population, which is more sensitive to such disorders, is propelling market growth. In accordance with this, the emergence of the coronavirus (covid-19) pandemic has increased the use of albumin in the creation of pharmaceuticals and stable vaccine compositions. Protein consumption is increasing as a result of the numerous benefits it provides. They are primarily employed in the development of critical medications. Protein is in high demand in Italy, the United States, and Belgium, for example. As a result, additional fractionation facilities are being built to meet demands and supply ratio. These technologies aid in the separation of plasma into albumin as well as other constituents. The advent of such labs is assisting the biopharma industries in developing cutting-edge goods for research, diagnosis, and therapies. Albumin is a popular choice when it comes to picking components for food items because it is free of artificial preservatives, which is boosting market demand for Albumin. Albumin is becoming extremely prevalent among health-conscious consumers because to its potential health benefits and lack of chemicals. However, the irrational uses and adverse reactions associated with albumin, and the rising shift toward serum-free solutions are hampering the market growth at the global level. Furthermore, the development of cost-effective therapeutics along with large scale production of albumin and high potential in untapped markets in the emerging economies are provided lucrative growth opportunities for the albumin market.Albumin Market Segment Analysis:
The Albumin Market is segmented by Product Type, Application, and End-User. Based on Product Type, the Albumin market is segmented Human Serum Albumin, Recombinant Albumin and Bovine Serum Albumin. The Human Serum Albumin segment held the largest market share of xx% in 2024 and is expected to continue this trend during the forecast period owing to large amounts of use in the treatment of burns, shock, and blood loss. It is also used in the pharmaceutical preparations, such as drug formulations and vaccines, and in cell culture media. Human serum albumin is the serum albumin originate in human blood. It is the most abundant protein in human blood plasma and constitutes about half of the serum proteins. It is produced in the liver and is soluble and monomeric. The rising formulations and increasing R&D, along with the growing of diseases, are driving the segment growth in the forecast period. Based on Application, the Albumin market is segmented into Drug Formulation, Drug Delivery, Vaccines, Medical Device Coating, Culture Medium & Stabilizer, Diagnostics and In Vitro Fertilization. The Drug Delivery segment held the largest market share of xx% in 2024 and this trend is estimated to continue over the forecast period. The usage of human serum albumin nanoparticles as a favored drug delivery system with applications for a wide range of diseases are fueling the market growth globally. The ongoing collaborations and joint ventures among the leading manufacturers in the albumin market is likely to offer significant boost to the growth of the market.Regional Insights:
Asia Pacific held the largest market share of xx% in 2024 and is expected to grow at a highest CAGR of 11.2% in the Albumin market during the forecast period. Due to rise in investments in life sciences by a large number of biopharmaceutical companies and research institutes. Rising demand for albumin is an emerging economies such as India and China. Hence, awareness programs conducted by organizations such as Plasma Protein Therapeutics Association (PPTA), which help to increase awareness about plasma donation and the different plasma protein therapies available along with their potential uses are expected to increase the uptake of these therapeutics in treating various conditions. The objective of the report is to present a comprehensive analysis of the Albumin Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also helps in understanding the Albumin Market dynamic, structure by analyzing the market segments and project the Albumin Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Albumin Market make the report investor’s guide.Albumin Market Scope: Inquire before buying
Global Albumin Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 5.95 Bn. Forecast Period 2025 to 2032 CAGR: 5.21% Market Size in 2032: USD 8.93 Bn. Segments Covered: by Product Type Human Serum Albumin Recombinant Albumin Bovine Serum Albumin by Application Drug Formulation Drug Delivery Vaccines Medical Device Coating Culture Medium & Stabilizer Diagnostics In Vitro Fertilization by End-User Pharmaceutical & Biotechnology Industry Research Institutes Albumin Market, by Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) North America (United States, Canada and Mexico) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Albumin Market, Key Players
1. Albumedix A/S 2. Albumin Therapeutics, LLC 3. Biotest AG 4. CSL Behring LLC 5. Grifols International, S.A. 6. HiMedia Laboratories Pvt. Ltd. 7. InVitria 8. Medxbio Pte Ltd. 9. Octapharma AG 10. RayBiotech, Inc. 11. SeraCare Life Sciences 12. Sigma-Aldrich Co. 13. Akron Biotech 14. Baxter International Inc. 15. Celgene Corporation, 16. Grifols SA 17. Merck KGaA 18. China Biologic Products Inc. 19. Shire Plc 20. Ventria Bioscience 21. Thermo Fisher Scientific 22. Novozymes A/S.Frequently Asked Questions:
1] What segments are covered in Albumin Market report? Ans. The segments covered in Albumin Market report are based on Product Type, Application, and End-User. 2] Which region is expected to hold the highest share in the Albumin Market? Ans. Asia Pacific is expected to hold the highest share in the Albumin Market. 3] What is the market size of Albumin Market by 2032? Ans. The market size of Albumin Market by 2032 is USD 8.93 Bn. 4] Who are the top key players in the Albumin Market? Ans. Albumedix A/S, Albumin Therapeutics, LLC, Biotest AG, CSL Behring LLC and Grifols International, S.A. are the top key players in the Albumin Market. 5] What was the Global Albumin Market size in 2024? Ans: The Global Albumin Market size was USD 5.95 Billion in 2024. 6] By End-User, What segments are covered in Albumin Market report? Ans. The segments covered in Albumin Market report by application are Pharmaceutical & Biotechnology Industry and Research Institutes.
1. Albumin Market: Research Methodology 2. Albumin Market Introduction 2.1. Study Assumption and Market Definition 2.2. Scope of the Study 2.3. Executive Summary 3. Albumin Market: Dynamics 3.1. Albumin Market Trends by Region 3.1.1. North America Albumin Market Trends 3.1.2. Europe Albumin Market Trends 3.1.3. Asia Pacific Albumin Market Trends 3.1.4. Middle East and Africa Albumin Market Trends 3.1.5. South America Albumin Market Trends 3.2. Albumin Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Albumin Market Drivers 3.2.1.2. North America Albumin Market Restraints 3.2.1.3. North America Albumin Market Opportunities 3.2.1.4. North America Albumin Market Challenges 3.2.2. Europe 3.2.2.1. Europe Albumin Market Drivers 3.2.2.2. Europe Albumin Market Restraints 3.2.2.3. Europe Albumin Market Opportunities 3.2.2.4. Europe Albumin Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Albumin Market Drivers 3.2.3.2. Asia Pacific Albumin Market Restraints 3.2.3.3. Asia Pacific Albumin Market Opportunities 3.2.3.4. Asia Pacific Albumin Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Albumin Market Drivers 3.2.4.2. Middle East and Africa Albumin Market Restraints 3.2.4.3. Middle East and Africa Albumin Market Opportunities 3.2.4.4. Middle East and Africa Albumin Market Challenges 3.2.5. South America 3.2.5.1. South America Albumin Market Drivers 3.2.5.2. South America Albumin Market Restraints 3.2.5.3. South America Albumin Market Opportunities 3.2.5.4. South America Albumin Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Application Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Albumin Market 3.8. Analysis of Government Schemes and Initiatives For Albumin Market 3.9. The Global Pandemic Impact on Albumin Market 3.10. Nanoparticle Formulations for Targeted Drug Delivery 3.11. Albumin-based Therapeutic Applications 4. Albumin Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 4.1. Albumin Market Size and Forecast, by Product Type (2024-2032) 4.1.1. Human Serum Albumin 4.1.2. Recombinant Albumin 4.1.3. Bovine Serum Albumin 4.2. Albumin Market Size and Forecast, by Application (2024-2032) 4.2.1. Drug Formulation 4.2.2. Drug Delivery 4.2.3. Vaccines 4.2.4. Medical Device Coating 4.2.5. Culture Medium & Stabilizer 4.2.6. Diagnostics 4.2.7. In Vitro Fertilization 4.3. Albumin Market Size and Forecast, by End-User (2024-2032) 4.3.1. Pharmaceutical & Biotechnology Industry 4.3.2. Research Institutes 4.4. Albumin Market Size and Forecast, by Region (2024-2032) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Albumin Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 5.1. North America Albumin Market Size and Forecast, by Product Type (2024-2032) 5.1.1. Human Serum Albumin 5.1.2. Recombinant Albumin 5.1.3. Bovine Serum Albumin 5.2. North America Albumin Market Size and Forecast, by Application (2024-2032) 5.2.1. Drug Formulation 5.2.2. Drug Delivery 5.2.3. Vaccines 5.2.4. Medical Device Coating 5.2.5. Culture Medium & Stabilizer 5.2.6. Diagnostics 5.2.7. In Vitro Fertilization 5.3. North America Albumin Market Size and Forecast, by End-User (2024-2032) 5.3.1. Pharmaceutical & Biotechnology Industry 5.3.2. Research Institutes 5.4. North America Albumin Market Size and Forecast, by Country (2024-2032) 5.4.1. United States 5.4.1.1. United States Albumin Market Size and Forecast, by Product Type (2024-2032) 5.4.1.1.1. Human Serum Albumin 5.4.1.1.2. Recombinant Albumin 5.4.1.1.3. Bovine Serum Albumin 5.4.1.2. United States Albumin Market Size and Forecast, by Application (2024-2032) 5.4.1.2.1. Drug Formulation 5.4.1.2.2. Drug Delivery 5.4.1.2.3. Vaccines 5.4.1.2.4. Medical Device Coating 5.4.1.2.5. Culture Medium & Stabilizer 5.4.1.2.6. Diagnostics 5.4.1.2.7. In Vitro Fertilization 5.4.1.3. United States Albumin Market Size and Forecast, by End-User (2024-2032) 5.4.1.3.1. Pharmaceutical & Biotechnology Industry 5.4.1.3.2. Research Institutes 5.4.2. Canada 5.4.2.1. Canada Albumin Market Size and Forecast, by Product Type (2024-2032) 5.4.2.1.1. Human Serum Albumin 5.4.2.1.2. Recombinant Albumin 5.4.2.1.3. Bovine Serum Albumin 5.4.2.2. Canada Albumin Market Size and Forecast, by Application (2024-2032) 5.4.2.2.1. Drug Formulation 5.4.2.2.2. Drug Delivery 5.4.2.2.3. Vaccines 5.4.2.2.4. Medical Device Coating 5.4.2.2.5. Culture Medium & Stabilizer 5.4.2.2.6. Diagnostics 5.4.2.2.7. In Vitro Fertilization 5.4.2.3. Canada Albumin Market Size and Forecast, by End-User (2024-2032) 5.4.2.3.1. Pharmaceutical & Biotechnology Industry 5.4.2.3.2. Research Institutes 5.4.3. Mexico 5.4.3.1. Mexico Albumin Market Size and Forecast, by Product Type (2024-2032) 5.4.3.1.1. Human Serum Albumin 5.4.3.1.2. Recombinant Albumin 5.4.3.1.3. Bovine Serum Albumin 5.4.3.2. Mexico Albumin Market Size and Forecast, by Application (2024-2032) 5.4.3.2.1. Drug Formulation 5.4.3.2.2. Drug Delivery 5.4.3.2.3. Vaccines 5.4.3.2.4. Medical Device Coating 5.4.3.2.5. Culture Medium & Stabilizer 5.4.3.2.6. Diagnostics 5.4.3.2.7. In Vitro Fertilization 5.4.3.3. Mexico Albumin Market Size and Forecast, by End-User (2024-2032) 5.4.3.3.1. Pharmaceutical & Biotechnology Industry 5.4.3.3.2. Research Institutes 6. Europe Albumin Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 6.1. Europe Albumin Market Size and Forecast, by Product Type (2024-2032) 6.2. Europe Albumin Market Size and Forecast, by Application (2024-2032) 6.3. Europe Albumin Market Size and Forecast, by End-User (2024-2032) 6.4. Europe Albumin Market Size and Forecast, by Country (2024-2032) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Albumin Market Size and Forecast, by Product Type (2024-2032) 6.4.1.2. United Kingdom Albumin Market Size and Forecast, by Application (2024-2032) 6.4.1.3. United Kingdom Albumin Market Size and Forecast, by End-User (2024-2032) 6.4.2. France 6.4.2.1. France Albumin Market Size and Forecast, by Product Type (2024-2032) 6.4.2.2. France Albumin Market Size and Forecast, by Application (2024-2032) 6.4.2.3. France Albumin Market Size and Forecast, by End-User (2024-2032) 6.4.3. Germany 6.4.3.1. Germany Albumin Market Size and Forecast, by Product Type (2024-2032) 6.4.3.2. Germany Albumin Market Size and Forecast, by Application (2024-2032) 6.4.3.3. Germany Albumin Market Size and Forecast, by End-User (2024-2032) 6.4.4. Italy 6.4.4.1. Italy Albumin Market Size and Forecast, by Product Type (2024-2032) 6.4.4.2. Italy Albumin Market Size and Forecast, by Application (2024-2032) 6.4.4.3. Italy Albumin Market Size and Forecast, by End-User (2024-2032) 6.4.5. Spain 6.4.5.1. Spain Albumin Market Size and Forecast, by Product Type (2024-2032) 6.4.5.2. Spain Albumin Market Size and Forecast, by Application (2024-2032) 6.4.5.3. Spain Albumin Market Size and Forecast, by End-User (2024-2032) 6.4.6. Sweden 6.4.6.1. Sweden Albumin Market Size and Forecast, by Product Type (2024-2032) 6.4.6.2. Sweden Albumin Market Size and Forecast, by Application (2024-2032) 6.4.6.3. Sweden Albumin Market Size and Forecast, by End-User (2024-2032) 6.4.7. Austria 6.4.7.1. Austria Albumin Market Size and Forecast, by Product Type (2024-2032) 6.4.7.2. Austria Albumin Market Size and Forecast, by Application (2024-2032) 6.4.7.3. Austria Albumin Market Size and Forecast, by End-User (2024-2032) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Albumin Market Size and Forecast, by Product Type (2024-2032) 6.4.8.2. Rest of Europe Albumin Market Size and Forecast, by Application (2024-2032) 6.4.8.3. Rest of Europe Albumin Market Size and Forecast, by End-User (2024-2032) 7. Asia Pacific Albumin Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 7.1. Asia Pacific Albumin Market Size and Forecast, by Product Type (2024-2032) 7.2. Asia Pacific Albumin Market Size and Forecast, by Application (2024-2032) 7.3. Asia Pacific Albumin Market Size and Forecast, by End-User (2024-2032) 7.4. Asia Pacific Albumin Market Size and Forecast, by Country (2024-2032) 7.4.1. China 7.4.1.1. China Albumin Market Size and Forecast, by Product Type (2024-2032) 7.4.1.2. China Albumin Market Size and Forecast, by Application (2024-2032) 7.4.1.3. China Albumin Market Size and Forecast, by End-User (2024-2032) 7.4.2. S Korea 7.4.2.1. S Korea Albumin Market Size and Forecast, by Product Type (2024-2032) 7.4.2.2. S Korea Albumin Market Size and Forecast, by Application (2024-2032) 7.4.2.3. S Korea Albumin Market Size and Forecast, by End-User (2024-2032) 7.4.3. Japan 7.4.3.1. Japan Albumin Market Size and Forecast, by Product Type (2024-2032) 7.4.3.2. Japan Albumin Market Size and Forecast, by Application (2024-2032) 7.4.3.3. Japan Albumin Market Size and Forecast, by End-User (2024-2032) 7.4.4. India 7.4.4.1. India Albumin Market Size and Forecast, by Product Type (2024-2032) 7.4.4.2. India Albumin Market Size and Forecast, by Application (2024-2032) 7.4.4.3. India Albumin Market Size and Forecast, by End-User (2024-2032) 7.4.5. Australia 7.4.5.1. Australia Albumin Market Size and Forecast, by Product Type (2024-2032) 7.4.5.2. Australia Albumin Market Size and Forecast, by Application (2024-2032) 7.4.5.3. Australia Albumin Market Size and Forecast, by End-User (2024-2032) 7.4.6. Indonesia 7.4.6.1. Indonesia Albumin Market Size and Forecast, by Product Type (2024-2032) 7.4.6.2. Indonesia Albumin Market Size and Forecast, by Application (2024-2032) 7.4.6.3. Indonesia Albumin Market Size and Forecast, by End-User (2024-2032) 7.4.7. Malaysia 7.4.7.1. Malaysia Albumin Market Size and Forecast, by Product Type (2024-2032) 7.4.7.2. Malaysia Albumin Market Size and Forecast, by Application (2024-2032) 7.4.7.3. Malaysia Albumin Market Size and Forecast, by End-User (2024-2032) 7.4.8. Vietnam 7.4.8.1. Vietnam Albumin Market Size and Forecast, by Product Type (2024-2032) 7.4.8.2. Vietnam Albumin Market Size and Forecast, by Application (2024-2032) 7.4.8.3. Vietnam Albumin Market Size and Forecast, by End-User (2024-2032) 7.4.9. Taiwan 7.4.9.1. Taiwan Albumin Market Size and Forecast, by Product Type (2024-2032) 7.4.9.2. Taiwan Albumin Market Size and Forecast, by Application (2024-2032) 7.4.9.3. Taiwan Albumin Market Size and Forecast, by End-User (2024-2032) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Albumin Market Size and Forecast, by Product Type (2024-2032) 7.4.10.2. Rest of Asia Pacific Albumin Market Size and Forecast, by Application (2024-2032) 7.4.10.3. Rest of Asia Pacific Albumin Market Size and Forecast, by End-User (2024-2032) 8. Middle East and Africa Albumin Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 8.1. Middle East and Africa Albumin Market Size and Forecast, by Product Type (2024-2032) 8.2. Middle East and Africa Albumin Market Size and Forecast, by Application (2024-2032) 8.3. Middle East and Africa Albumin Market Size and Forecast, by End-User (2024-2032) 8.4. Middle East and Africa Albumin Market Size and Forecast, by Country (2024-2032) 8.4.1. South Africa 8.4.1.1. South Africa Albumin Market Size and Forecast, by Product Type (2024-2032) 8.4.1.2. South Africa Albumin Market Size and Forecast, by Application (2024-2032) 8.4.1.3. South Africa Albumin Market Size and Forecast, by End-User (2024-2032) 8.4.2. GCC 8.4.2.1. GCC Albumin Market Size and Forecast, by Product Type (2024-2032) 8.4.2.2. GCC Albumin Market Size and Forecast, by Application (2024-2032) 8.4.2.3. GCC Albumin Market Size and Forecast, by End-User (2024-2032) 8.4.3. Nigeria 8.4.3.1. Nigeria Albumin Market Size and Forecast, by Product Type (2024-2032) 8.4.3.2. Nigeria Albumin Market Size and Forecast, by Application (2024-2032) 8.4.3.3. Nigeria Albumin Market Size and Forecast, by End-User (2024-2032) 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Albumin Market Size and Forecast, by Product Type (2024-2032) 8.4.4.2. Rest of ME&A Albumin Market Size and Forecast, by Application (2024-2032) 8.4.4.3. Rest of ME&A Albumin Market Size and Forecast, by End-User (2024-2032) 9. South America Albumin Market Size and Forecast by Segmentation (by Value in USD Million) (2024-2032) 9.1. South America Albumin Market Size and Forecast, by Product Type (2024-2032) 9.2. South America Albumin Market Size and Forecast, by Application (2024-2032) 9.3. South America Albumin Market Size and Forecast, by End-User (2024-2032) 9.4. South America Albumin Market Size and Forecast, by Country (2024-2032) 9.4.1. Brazil 9.4.1.1. Brazil Albumin Market Size and Forecast, by Product Type (2024-2032) 9.4.1.2. Brazil Albumin Market Size and Forecast, by Application (2024-2032) 9.4.1.3. Brazil Albumin Market Size and Forecast, by End-User (2024-2032) 9.4.2. Argentina 9.4.2.1. Argentina Albumin Market Size and Forecast, by Product Type (2024-2032) 9.4.2.2. Argentina Albumin Market Size and Forecast, by Application (2024-2032) 9.4.2.3. Argentina Albumin Market Size and Forecast, by End-User (2024-2032) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Albumin Market Size and Forecast, by Product Type (2024-2032) 9.4.3.2. Rest Of South America Albumin Market Size and Forecast, by Application (2024-2032) 9.4.3.3. Rest Of South America Albumin Market Size and Forecast, by End-User (2024-2032) 10. Global Albumin Market: Competitive Landscape 10.1. MMR Competition Matrix 10.2. Competitive Landscape 10.3. Key Players Benchmarking 10.3.1. Company Name 10.3.2. Service Segment 10.3.3. End-user Segment 10.3.4. Revenue (2024) 10.3.5. Company Locations 10.4. Leading Albumin Market Companies, by Market Capitalization 10.5. Market Structure 10.5.1. Market Leaders 10.5.2. Market Followers 10.5.3. Emerging Players 10.6. Mergers and Acquisitions Details 11. Company Profile: Key Players 11.1. Albumedix A/S 11.1.1. Company Overview 11.1.2. Business Portfolio 11.1.3. Financial Overview 11.1.4. SWOT Analysis 11.1.5. Strategic Analysis 11.1.6. Recent Developments 11.2. Albumin Therapeutics, LLC 11.3. Biotest AG 11.4. CSL Behring LLC 11.5. Grifols International, S.A. 11.6. HiMedia Laboratories Pvt. Ltd. 11.7. InVitria 11.8. Medxbio Pte Ltd. 11.9. Octapharma AG 11.10. RayBiotech, Inc. 11.11. SeraCare Life Sciences 11.12. Sigma-Aldrich Co. 11.13. Akron Biotech 11.14. Baxter International Inc. 11.15. Celgene Corporation, 11.16. Grifols SA 11.17. Merck KGaA 11.18. China Biologic Products Inc. 11.19. Shire Plc 11.20. Ventria Bioscience 11.21. Thermo Fisher Scientific 11.22. Novozymes A/S. 12. Key Findings 13. Industry Recommendations
